An open-label multi-center study of ATI-5923 for anticoagulation in patients with atrial fibrillation
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Tecarfarin (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- Sponsors ARYx Therapeutics
- 31 Aug 2018 Biomarkers information updated
- 10 Nov 2007 Status changed from recruiting to completed.
- 02 Mar 2007 New trial record.